Abstract
A plenty of gene mutations causing cardiomyopathies have been identified and their relationship with the clinical outcomes is being discussed. At least in hypertrophic cardiomyopathy (HCM), genomic analysis of sarcomere protein gene mutations could convince us of the diagnosis of the disease. The variety of sarcomere protein gene mutations can partly explain the great diversity of clinical manifestation of HCM. Even in HCM, however, there remain some limitations that retard practical application of genetic diagnosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.